Analyst & Firm | Company | Price | Rating & Price Target | Upside / Downside | Success Rate | Average Return | Action | Date | Article |
---|---|---|---|---|---|---|---|---|---|
PLUXEE N.V. | HOLD €26 | ― | -15.60% | Reiterated | Barclays Sticks to Their Hold Rating for PLUXEE N.V. (PLX) | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €78→€83 | ― | 17.20% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €85 | ― | 28.30% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €115→€122 | ― | 12.70% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €28.3 | ― | 16.60% | Assigned | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €122 | ― | 0.80% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €250 | ― | 1.80% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €260 | ― | 4.60% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €180 | ― | 4.60% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €195 | ― | 4.60% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €130 | ― | 7.30% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL €195 | ― | 15.50% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €67 | ― | 18.20% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €230 | ― | 7.00% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €64 | ― | 0.80% | Reiterated | ||||
Societe BIC SA | HOLD €67 | ― | -1.70% | Reiterated | UBS Sticks to Its Hold Rating for Societe BIC SA (0MGP) | ||||
LVMH Moet Hennessy Louis Vuitton | BUY €650 | ― | -4.50% | Reiterated | |||||
Kering SA | HOLD €230 | ― | -4.50% | Reiterated | RBC Capital Sticks to Its Hold Rating for Kering SA (0IIH) | ||||
Schneider Electric | BUY €275 | ― | -0.70% | Reiterated | Bernstein Reaffirms Their Buy Rating on Schneider Electric (0NWV) | ||||
EssilorLuxottica SA | HOLD €205 | ― | -4.50% | Reiterated | EssilorLuxottica SA (0OMK) Gets a Hold from RBC Capital | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €215→€225 | ― | 4.60% | Reiterated | ||||
EDENRED | HOLD €38→€32 | ― | -3.10% | Reiterated | Citi Reiterates Neutral Rating on Edenred (EDEN:FP) (EDNMY)Citi analyst Pavan Daswani reiterated a Neutral rating and EUR32.00 price target on Edenred (EDEN:FP) (OTC: EDNMY). | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €36 | ― | 8.50% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL €15.5→€13.5 | ― | 22.40% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €109→€140 | ― | 9.10% | Upgraded | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL €53→€45 | ― | 1.70% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €397→€347 | ― | 1.40% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €127→€111 | ― | 1.40% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €63→€69 | ― | 1.40% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €65→€52 | ― | 1.40% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €248 | ― | 9.70% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €12.05 | ― | 1.90% | Reiterated | ||||
AIR France KLM | BUY €10 | ― | -15.70% | Reiterated | AIR France KLM (0LN7) Receives a Buy from J.P. Morgan | ||||
Technip Energies NV | SELL €26 | ― | -4.30% | Downgraded | JPMorgan Downgrades Technip Energies NV (TE:FP) to UnderweightJPMorgan analyst Kate Somerville downgraded Technip Energies NV (TE:FP) from Neutral to Underweight with a price target of EUR26.00. | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €142→€130 | ― | 18.80% | Downgraded | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €47→€52 | ― | 1.90% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €4.7→€4.5 | ― | 1.90% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €82.5 | ― | 22.40% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €14 | ― | 4.60% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €12.3→€12.1 | ― | 9.10% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €130 | ― | 8.40% | Initiated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €26.6→€29.25 | ― | 22.40% | Upgraded | ||||
Sopra Steria | BUY €280 | ― | -7.50% | Reiterated | Sopra Steria (0NJQ) Gets a Buy from Kepler Capital | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €33 | ― | 17.20% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €14 | ― | 0.30% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €18.3 | ― | 20.70% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €47 | ― | 4.70% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €180 | ― | 9.60% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €66→€61 | ― | 3.70% | Reiterated | ||||
Nanobiotix | BUY €16 | ― | -18.70% | Assigned | Nanobiotix's NBTXR3 Clinical Advancements: Promising Outcomes and Strategic Expansion Drive Buy Rating |